The prognostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for CVD outcomes in patients with diabetes has been demonstrated and was confirmed in numerous studies [7–24]. This evidence concerns the gene NPPB and diabetes mellitus.